The Belgian Damier Group has acquired Bärbel Drexel GmbH from the private equity firm Finatem. In Germany, Bärbel Drexel is one of the leading suppliers of natural food supplements and natural cosmetics. The company has a well-established brand aimed at a 45+ target group, develops and produces in-house, and sells directly through catalogs, e-commerce, and teleshopping. Through the acquisition of Bärbel Drexel GmbH, Damier strengthens its profile in the field of consumer health care in the German market.
Quarton International was mandated as an exclusive adviser to the company and the majority shareholders.
Bärbel Drexel GmbH is a leading provider of natural food supplements and natural cosmetics in Germany. The company provides for a diversified customer base through the channels of e-commerce, teleshopping, and catalog mail order business. Bärbel Drexel GmbH was founded in Baar (Swabia) in 1996 by the alternative practitioner Bärbel Drexel and her husband using her own naturopathic competence. In 2003, the financial investor Finatem took over the majority of the shares from the founding members.
Damier Group is the Belgian industrial holding company of Yvan Vindevogel, the founder of Vemedia Pharma and Omega Pharma. The Group’s investments are focused on European companies with established brands or innovative technological solutions in the areas of consumer health care and leisure. The subsidiaries are active in Belgium, France, the Netherlands, and Germany. Companies acquired by the Group are integrated into the extensive network of existing holdings, in order to realize synergies.